Gearóid M. Faherty
Chief Executive Officer
|
|
|
Gearóid M. Faherty has been an executive director and Chairman and Chief Executive Officer of Eurand since April 1999. He directed the Eurand business while it was owned by American Home Products Corporation subsidiary, Fort Dodge, Animal Health, and has held positions at subsidiaries of Sterling Drug and Pfizer. Mr. Faherty completed his Bachelor of Science degree at University College Galway, Ireland, and has a Masters degree in chemical engineering and biotechnology from the National University of Ireland. |
Mario P. Crovetto
Chief Financial Officer
|
|
|
Mario P. Crovetto joined Eurand as Chief Financial Officer in October 1999. From 1990 to 1999, Mr. Crovetto held various positions at Recordati, including Vice President Corporate Development from 1995 to 1999, Division Manager of Diagnostics from 1993 to 1995 and Chief Financial Officer from 1990 to 1993. Additionally, he has held various positions at Montedison (Fine and Specialty Chemicals), Digital Equipment Corporation and Mobil. Mr. Crovetto holds a Bachelor of Science degree in economics from the Catholic University Milan and a Masters degree in business economics from Harvard University. |
Manya S. Deehr
Chief Legal Officer
|
|
|
Manya S. Deehr joined the company as Chief Legal Officer and Corporate Secretary in February 2007. From October 2000 to January 2007, Ms. Deehr was a partner in the business and finance practice of Morgan Lewis & Bockius LLP, where she worked exclusively with life sciences companies. Prior to joining Morgan Lewis, she was, among other things, Vice President, General Counsel and Corporate Secretary for an early-stage drug discovery company and a law clerk for the Honorable Giles S. Rich on U.S. Court of Appeals for the Federal Circuit. She is admitted to practice in Pennsylvania, California, Colorado and the U.S. Patent and Trademark Office and before the U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit. Ms. Deehr also serves as a director on the board of Pennsylvania Biotechnology Association, a non-profit industry organization; and as a director and member of the audit committee of Velcera Pharmaceuticals, Inc., a veterinary health company. Ms. Deehr has a law degree from the University of Wisconsin Law School and a bachelors degree in biochemical sciences from Harvard University. |
John J. Fraher
Chief Commercial Officer
|
|
|
John J. Fraher has been the Chief Commercial Officer of Eurand since August 2006, the President of Eurand, Incorporated, since April 1999 and was the Vice President of Eurand, Incorporated, from 1995 to April 1999. Previously, Mr. Fraher was Production Manager at American Home Products Corporation's affiliate, Fort Dodge Laboratories, located in Ireland, and has worked at Sterling Drug in Ireland. Mr. Fraher holds a degree in biochemistry from University College Dublin, Ireland. |
Robert Becker
Chief Research Officer
|
|
Robert Becker joined Eurand’s Italian subsidiary, Eurand S.p.A., as Chief Research Officer in April 2009 and is responsible for all global research and formulation activities. Prior to joining Eurand, Dr. Becker has held various leading positions at Boehringer-Ingelheim, Eli Lilly & Co. and Biogen Idec, including Director Pharmaceutical R&D and Senior Director Biopharmaceutical Development, with the focus on oral drug delivery and solubility improvement. Dr. Becker holds a degree in Chemistry and a Ph.D. in Physical Chemistry from the Technical University of Munich.
|
Ruth Thieroff-Ekerdt, M.D.
Chief Medical Officer
|
|
|
Ruth Thieroff-Ekerdt joined Eurand's U.S. subsidiary, Eurand Pharmaceuticals, Inc., as Chief Medical Officer in December 2008. Dr. Ekerdt is responsible for portfolio development, clinical research and development, medical and regulatory affairs, and drug safety and surveillance activities. Prior to joining Eurand, she held various positions with Berlex, Inc., including Vice President Medical Development Management and Operations, Vice President Clinical Development, and Director of Clinical Development, Dermatology. Dr. Ekerdt graduated from the Medical School at the University of Erlangen, Bavaria, and Free University of Berlin. She holds an M.D. and specialized in Pharmacology / Toxicology.
|
Michael J. Walters
Executive Vice President
|
|
|
Michael J. Walters joined Eurand's U.S. subsidiary, Eurand Pharmaceuticals, Inc., as Executive Vice President of Sales and Marketing in December 2007 and is responsible for the anticipated U.S. commercial launch of the Company's pancreatic enzyme product, EUR-1008 (ZENPEP™). Prior to joining Eurand, Mr. Walters was President and CEO of SourceCF, a company he co-founded in July 2001 which focused on serving the needs of Cystic Fibrosis (CF) patients, physicians and care givers, and which was acquired by Eurand in December 2007. Additionally, Mr. Walters was involved in the management of the launch of TOBI® for PathoGenesis. He served in various managerial positions of progressively increasing responsibility at Ortho-McNeil Pharmaceuticals (Johnson & Johnson), including Director of Management Development and Director of Training and Regional Sales Manager. Mr. Walters holds a Bachelor of Science degree in Molecular Biology and Chemistry from Vanderbilt University.
|